On 5/28/24, Agios Pharmaceuticals Inc (NASDAQ: AGIO) stock enjoyed a major increase of 23.2%, closing at $38.81. Moreover, exceptionally high trading volume at 507% of normal accompanied the advance. The stock has been exceptionally strong relative to the market over the last nine months and has risen 13.0% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, AGIO is expected to be a modest Value Builder.
Agios Pharmaceuticals has a current Value Trend Rating of C (Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Agios Pharmaceuticals has a poor Appreciation Score of 16 but a very high Power Rating of 85, resulting in the Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment